{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:49:36Z","timestamp":1790304576020,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e33976","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T05:30:08Z","timestamp":1719898208000},"page":"e33976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clues of HLAs, metabolic SNPs, and epigenetic factors in T cell-mediated drug hypersensitivity reactions"],"prefix":"10.1016","volume":"10","author":[{"given":"Rasol","family":"Molatefi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedighe","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Samei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Roshanravan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Manshouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baran","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Ghobadi Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Mosharkesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholeh","family":"Khajoei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1275-2157","authenticated-orcid":false,"given":"Farhad","family":"Seif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heliyon.2024.e33976_bib1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and risk factors for drug allergy","volume":"71","author":"Thong","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib2","first-page":"143","article-title":"Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity","volume":"24","author":"Do\u00f1a","year":"2014","journal-title":"J Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e33976_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1067463","article-title":"HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes","volume":"13","author":"Karnaukhov","year":"2022","journal-title":"Front. Immunol."},{"issue":"29\u201330","key":"10.1016\/j.heliyon.2024.e33976_bib4","first-page":"501","article-title":"Drug hypersensitivity: diagnosis, genetics, and prevention","volume":"115","author":"B\u00f6hm","year":"2018","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1016\/j.heliyon.2024.e33976_bib5","series-title":"Mechanisms of Adverse Drug Reactions to Biologics. Adverse Drug Reactions","first-page":"453","author":"Clarke","year":"2010"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33976_bib6","article-title":"Drug allergy. Allergy","volume":"7","author":"Warrington","year":"2011","journal-title":"Asthma & Clinical Immunology"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33976_bib34","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jaip.2019.06.001","article-title":"Cephalosporin allergy: current understanding and future challenges","volume":"7","author":"Khan","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.heliyon.2024.e33976_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fphar.2016.00396","article-title":"Pharmacogenetics and predictive testing of drug hypersensitivity reactions","volume":"7","author":"Bohm","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"29\u201330","key":"10.1016\/j.heliyon.2024.e33976_bib8","first-page":"501","article-title":"Drug hypersensitivity","volume":"115","author":"Bohm","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.heliyon.2024.e33976_bib9","series-title":"Drug Allergy: Clinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships","author":"Baldo","year":"2013"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33976_bib10","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/all.14061","article-title":"Recent developments and highlights in drug hypersensitivity","volume":"74","author":"Mayorga","year":"2019","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib11","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33976_bib12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and risk factors for drug allergy","volume":"71","author":"Thong","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000458725","article-title":"Multiple drug hypersensitivity","volume":"172","author":"Pichler","year":"2017","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.heliyon.2024.e33976_bib14","series-title":"Physiology and Pathology of Immunology","article-title":"Physiology and Pathology of drug hypersensitivity: role of human leukocyte antigens","author":"Simper","year":"2017"},{"key":"10.1016\/j.heliyon.2024.e33976_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.actatropica.2018.02.026","article-title":"Erythema Nodosum Leprosum: update and challenges on the treatment of a neglected condition","volume":"183","author":"Costa","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.heliyon.2024.e33976_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.36347\/sajb.2024.v12i04.005","article-title":"Allergic Management Strategies: An Update of the Literature","volume":"4","author":"Salameh","year":"2024","journal-title":"Sch Acad J Biosci"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33976_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The lymphocyte transformation test in the diagnosis of drug hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.heliyon.2024.e33976_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.seizure.2019.07.015","article-title":"Rashes and other hypersensitivity reactions associated with antiepileptic drugs: a review of current literature","volume":"71","author":"Mani","year":"2019","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jaci.2022.12.005","article-title":"Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions","volume":"151","author":"Gibson","year":"2023","journal-title":"Journal of allergy and clinical immunology"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e33976_bib20","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/cid\/cix096","article-title":"Association of the HLA-B* 53: 01 allele with drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome during treatment of HIV infection with raltegravir","volume":"64","author":"Thomas","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e33976_bib21","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/cid\/cit021","article-title":"Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population","volume":"56","author":"Carr","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e33976_bib22","first-page":"139","volume":"vol. 97","author":"Sidoroff","year":"2012"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33976_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jdcr.2014.09.004","article-title":"Acute generalized exanthematous pustulosis associated with primary Epstein-Barr virus infection","volume":"1","author":"Ropars","year":"2015","journal-title":"JAAD Case Reports"},{"issue":"7777","key":"10.1016\/j.heliyon.2024.e33976_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","article-title":"Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming","volume":"574","author":"B\u00e9n\u00e9chet","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaci.2015.06.022","article-title":"New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity","volume":"136","author":"Pirmohamed","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.26077","article-title":"Human leukocyte antigen (HLA)\u2010B* 57: 01\u2010restricted activation of drug\u2010specific T cells provides the immunological basis for flucloxacillin\u2010induced liver injury","volume":"57","author":"Monshi","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib27","first-page":"160","article-title":"Clinical characteristics of patients with drug-induced liver injury","volume":"130","author":"Yang","year":"2017","journal-title":"Chinese medical journal"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33976_bib28","article-title":"Drug-induced renal injury: the kidney plays an important role in the elimination of many drugs and their metabolites","volume":"29","author":"Decloedt","year":"2011","journal-title":"Cont. Med. Educ."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33976_bib29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/all.15126","article-title":"Advances and highlights in T and B cell responses to drug antigens","volume":"77","author":"Fernandez\u2010Santamaria","year":"2022","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33976_bib107","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: testing for delayed reactions","volume":"143","author":"Phillips","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e33976_bib30","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.jaci.2010.11.048","article-title":"Immune pathomechanism of drug hypersensitivity reactions","volume":"127","author":"Pichler","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33976_bib31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40264-019-00825-2","article-title":"Mechanisms of severe cutaneous adverse reactions: recent advances","volume":"42","author":"Bellon","year":"2019","journal-title":"Drug Saf."},{"key":"10.1016\/j.heliyon.2024.e33976_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-med-050913-022745","article-title":"T cell-mediated hypersensitivity reactions to drugs","volume":"66","author":"Pavlos","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"Suppl 2","key":"10.1016\/j.heliyon.2024.e33976_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13223-018-0289-y","article-title":"Drug allergy","volume":"14","author":"Warrington","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33976_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3349\/ymj.2016.57.1.118","article-title":"HLA allele frequencies in 5802 Koreans: varied allele types associated with SJS\/TEN according to culprit drugs","volume":"57","author":"Park","year":"2016","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.heliyon.2024.e33976_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/565320","article-title":"HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review","volume":"2014","author":"Cheng","year":"2014","journal-title":"Journal of immunology research"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000448217","article-title":"HLA and delayed drug-induced hypersensitivity","volume":"170","author":"Sousa-Pinto","year":"2016","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33976_bib38","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","article-title":"Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome","volume":"129","author":"Wei","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2024.e33976_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6431694","article-title":"An updated review of the molecular mechanisms in drug hypersensitivity","volume":"2018","author":"Chen","year":"2018","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33976_bib40","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B* 5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"7404","key":"10.1016\/j.heliyon.2024.e33976_bib41","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2023.03.029","article-title":"Development of mouse models with restricted HLA-B\u2217 57: 01 presentation for the study of flucloxacillin-driven T-cell activation and tolerance in liver injury","volume":"152","author":"Ananthula","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33976_bib43","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/all.14061","article-title":"Recent developments and highlights in drug hypersensitivity","volume":"74","author":"Mayorga","year":"2019","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33976_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076211","article-title":"Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRV\u03b220-1, altering pHLA recognition","volume":"8","author":"Watkins","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33976_bib45","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/jdv.17980","article-title":"Unique motif shared by HLA\u2010B* 59: 01 and HLA\u2010B* 55: 02 is associated with methazolamide\u2010induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Han Chinese","volume":"36","author":"Jiang","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.heliyon.2024.e33976_bib46","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fgene.2019.00582","article-title":"Identification of novel biomarkers for drug hypersensitivity after sequencing of the promoter area in 16 genes of the vitamin D pathway and the high-affinity IgE receptor","author":"Amo","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.heliyon.2024.e33976_bib47","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.5415\/apallergy.2020.10.e8","article-title":"Drug hypersensitivity reactions in Asia: regional issues and challenges","volume":"10","author":"Thong","year":"2020","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.heliyon.2024.e33976_bib48","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fphar.2016.00396","article-title":"Pharmacogenetics and predictive testing of drug hypersensitivity reactions","volume":"7","author":"B\u00f6hm","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33976_bib71","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/all.13769","article-title":"Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01","volume":"74","author":"Zhao","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.heliyon.2024.e33976_bib72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fgene.2018.00277","article-title":"HLA pharmacogenetic markers of drug hypersensitivity in a Thai population","volume":"9","author":"Nakkam","year":"2018","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33976_bib73","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00228-017-2250-2","article-title":"Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions","volume":"73","author":"Yampayon","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33976_bib74","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.2014.7859","article-title":"Genetic variants associated with phenytoin-related severe cutaneous adverse reactions","volume":"312","author":"Chung","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33976_bib75","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/cpt.1004","article-title":"Clinical pharmacogenetics implementation consortium guideline for HLA genotype and use of carbamazepine and oxcarbazepine: 2017 update","volume":"103","author":"Phillips","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e33976_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2016.05.003","article-title":"Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions","volume":"42","author":"Illing","year":"2016","journal-title":"Curr. Opin. Immunol."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e33976_bib77","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1212\/WNL.0000000000004008","article-title":"HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions","volume":"88","author":"Shi","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib78","first-page":"197","article-title":"Association of HLA genotypes with Beta-lactam antibiotic hypersensitivity in children","volume":"39","author":"Singvijarn","year":"2021","journal-title":"Asian Pacific Journal of Allergy and Immunology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33976_bib79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/cod.12849","article-title":"Nevirapine patch testing in Thai human immunodeficiency virus infected patients with nevirapine drug hypersensitivity","volume":"77","author":"Prasertvit","year":"2017","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib80","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaci.2015.06.022","article-title":"New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity","volume":"136","author":"Pirmohamed","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33976_bib81","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B* 5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib82","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41397-019-0143-8","article-title":"Association of carbamazepine-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B* 15: 21 allele in Filipino patients","volume":"20","author":"Capule","year":"2020","journal-title":"Pharmacogenomics J."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33976_bib83","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/14622416.7.6.813","article-title":"HLA-B locus in Caucasian patients with carbamazepine hypersensitivity","volume":"7","author":"Alfirevic","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.heliyon.2024.e33976_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7863815","article-title":"Pulmonary manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review","volume":"2019","author":"Taweesedt","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"15","key":"10.1016\/j.heliyon.2024.e33976_bib85","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2217\/pgs.13.180","article-title":"Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects","volume":"14","author":"Kaniwa","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33976_bib86","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1365-2222.2012.04078.x","article-title":"Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria","volume":"42","author":"Cornejo-Garcia","year":"2012","journal-title":"Clin. Exp. Allergy"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33976_bib87","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2217\/pgs.15.43","article-title":"Genetic variants in arachidonic acid pathway genes associated with NSAID-exacerbated respiratory disease","volume":"16","author":"Ayuso","year":"2015","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33976_bib88","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2013.04.045","article-title":"Association of thromboxane A1 synthase (TBXAS1) gene polymorphism with acute urticaria induced by nonsteroidal anti-inflammatory drugs","volume":"132","author":"Vidal","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e33976_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013818","article-title":"Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma","volume":"5","author":"Kim","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090966","article-title":"Variants of CEP68 gene are associated with acute urticaria\/angioedema induced by multiple non-steroidal anti-inflammatory drugs","volume":"9","author":"Cornejo-Garcia","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib91","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00439-012-1247-2","article-title":"Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population","volume":"132","author":"Park","year":"2013","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33976_bib92","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/MLG.0b013e31816b4b6f","article-title":"Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma","volume":"118","author":"Stankovic","year":"2008","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33976_bib93","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00438-012-0685-9","article-title":"Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD","volume":"287","author":"Shin","year":"2012","journal-title":"Mol Genet Genomics"},{"key":"10.1016\/j.heliyon.2024.e33976_bib94","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/ncomms5757","article-title":"Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles","volume":"5","author":"Goldstein","year":"2014","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33976_bib95","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/acr.21671","article-title":"Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33976_bib96","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury","volume":"42","author":"Singer","year":"2010","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33976_bib97","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33976_bib98","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2010.31.3197","article-title":"HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer","volume":"29","author":"Spraggs","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33976_bib99","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/clpt.2011.277","article-title":"Lapatinib-induced liver injury characterized by class II HLA and Gilbert's syndrome genotypes","volume":"91","author":"Spraggs","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e33976_bib100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/FPC.0b013e32832c347d","article-title":"High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients","volume":"19","author":"Kazeem","year":"2009","journal-title":"Pharmacogenet Genomics."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib101","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2222.2004.02197.x","article-title":"The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria","volume":"35","author":"Kim","year":"2005","journal-title":"Clin. Exp. Allergy"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33976_bib102","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/ACI.0b013e32833b1eb3","article-title":"Genetic and ethnic risk factors associated with drug hypersensitivity","volume":"10","author":"Kim","year":"2010","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib103","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00420-019-01417-4","article-title":"Joint association of carrying HLA-B*13:01 gene and human herpesvirus-6 with occupational trichloroethylene hypersensitivity syndrome","volume":"92","author":"Wang","year":"2019","journal-title":"Int. Arch. Occup. Environ. Health"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33976_bib104","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/j.gastro.2016.12.016","article-title":"Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study","volume":"152","author":"Nicoletti","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33976_bib105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/FPC.0000000000000209","article-title":"HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury","volume":"26","author":"Nicoletti","year":"2016","journal-title":"Pharmacogenet Genomics"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33976_bib106","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(16)00113-3","article-title":"Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population","volume":"4","author":"Hallberg","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/gene.2013.2","article-title":"A PheWAS approach in studying HLA-DRB1* 1501","volume":"14","author":"Hebbring","year":"2013","journal-title":"Gene Immun."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33976_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/toxsci\/kfaa128","article-title":"Hla DRB1* 15: 01-DQB1* 06: 02-restricted human CD4+ T cells are selectively activated with amoxicillin-peptide adducts","volume":"178","author":"Tailor","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33976_bib51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaci.2014.07.047","article-title":"HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping","volume":"135","author":"Gu\u00e9ant","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/tx400460w","article-title":"HLA restriction of carbamazepine-specific T-Cell clones from an HLA-A* 31: 01-positive hypersensitive patient","volume":"27","author":"Lichtenfels","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33976_bib53","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/ACI.0000000000000459","article-title":"Genetic and nongenetic factors that may predispose individuals to allergic drug reactions","volume":"18","author":"Gibson","year":"2018","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33976_bib54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00228-006-0245-5","article-title":"Association of IL-10 level and IL-10 promoter SNPs with specific antibodies in penicillin-allergic patients","volume":"63","author":"Qiao","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33976_bib55","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.fpc.0000230409.00276.44","article-title":"Gene\u2013gene interactions of IL13 and IL4RA variants in immediate allergic reactions to betalactam antibiotics","volume":"16","author":"Gu\u00e9ant-Rodriguez","year":"2006","journal-title":"Pharmacogenetics Genom."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/tpj.2016.10","article-title":"Association of HLA-B* 15: 13 and HLA-B* 15: 02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population","volume":"17","author":"Chang","year":"2017","journal-title":"Pharmacogenomics J."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e33976_bib57","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00228-013-1549-x","article-title":"Association between CYP2B6 polymorphisms and Nevirapine-induced SJS\/TEN: a pharmacogenetics study","volume":"69","author":"Ciccacci","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e33976_bib58","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00228-017-2295-2","article-title":"Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS\/TEN susceptibility","volume":"73","author":"Ciccacci","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33976_bib59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenetics Genom."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33976_bib60","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/cpt.343","article-title":"DNA methylation of ADME genes","volume":"99","author":"Fisel","year":"2016","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33976_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-015-0136-7","article-title":"Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes","volume":"7","author":"Habano","year":"2015","journal-title":"Clin. Epigenet."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib62","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/03602532.2022.2064488","article-title":"Impact of DNA methylation on ADME gene expression, drug disposition, and efficacy","volume":"54","author":"Hao","year":"2022","journal-title":"Drug Metabol. Rev."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e33976_bib63","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1074\/jbc.M806193200","article-title":"Epigenetic regulation of transcriptional activity of pregnane X receptor by protein arginine methyltransferase 1","volume":"284","author":"Xie","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33976_bib64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1124\/mol.117.108225","article-title":"Alterations of histone modifications contribute to pregnane X receptor-mediated induction of CYP3A4 by rifampicin","volume":"92","author":"Yan","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e33976_bib65","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bcp.2018.07.018","article-title":"Human ATP-binding cassette transporters ABCB1 and ABCG2 confer resistance to histone deacetylase 6 inhibitor ricolinostat (ACY-1215) in cancer cell lines","volume":"155","author":"Wu","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33976_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132992","article-title":"Differences in the epigenetic regulation of cytochrome P450 genes between human embryonic stem cell-derived hepatocytes and primary hepatocytes","volume":"10","author":"Park","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33976_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122820","article-title":"Developmental regulation and induction of cytochrome P450 2W1, an enzyme expressed in colon tumors","volume":"10","author":"Choong","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33976_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-018-0157-3","article-title":"Integrating rare genetic variants into pharmacogenetic drug response predictions","volume":"12","author":"Ingelman-Sundberg","year":"2018","journal-title":"Hum. Genom."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e33976_bib69","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/nchem.2064","article-title":"5-Hydroxymethylcytosine is a predominantly stable DNA modification","volume":"6","author":"Bachman","year":"2014","journal-title":"Nat. Chem."},{"key":"10.1016\/j.heliyon.2024.e33976_bib70","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pharmthera.2019.01.002","article-title":"Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity","volume":"197","author":"Lauschke","year":"2019","journal-title":"Pharmacol. Ther."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024100072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024100072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:27:40Z","timestamp":1773840460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024100072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":107,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024100072"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33976","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clues of HLAs, metabolic SNPs, and epigenetic factors in T cell-mediated drug hypersensitivity reactions","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e33976"}}